The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic

With an estimated population of 8.3 million, Sierra Leone has no existing pharmaceutical manufacturing company at present. The recent COVID-19 pandemic brought to the limelight the fragility and weakness of the Sierra Leonean pharmaceutical industry as it resulted in severe drug shortages and medici...

Descripción completa

Detalles Bibliográficos
Autores principales: Conteh, Eugene, Okereke, Melody, Turay, Foday Umaro, Bah, Alhaji Sununu, Muhsinah, Abdulwasiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326415/
https://www.ncbi.nlm.nih.gov/pubmed/35897056
http://dx.doi.org/10.1186/s40545-022-00444-w
_version_ 1784757279881428992
author Conteh, Eugene
Okereke, Melody
Turay, Foday Umaro
Bah, Alhaji Sununu
Muhsinah, Abdulwasiu
author_facet Conteh, Eugene
Okereke, Melody
Turay, Foday Umaro
Bah, Alhaji Sununu
Muhsinah, Abdulwasiu
author_sort Conteh, Eugene
collection PubMed
description With an estimated population of 8.3 million, Sierra Leone has no existing pharmaceutical manufacturing company at present. The recent COVID-19 pandemic brought to the limelight the fragility and weakness of the Sierra Leonean pharmaceutical industry as it resulted in severe drug shortages and medicine insecurity in the country due to the restrictions imposed on importations, which validates the uncertainties if the country can sufficiently meet its local pharmaceutical needs and health demands. In this paper, we highlight the current situation of the Sierra Leonean pharmaceutical sector and provide recommendations for the country towards building a functional pharmaceutical industry based on lessons learnt from the COVID-19 pandemic.
format Online
Article
Text
id pubmed-9326415
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93264152022-07-27 The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic Conteh, Eugene Okereke, Melody Turay, Foday Umaro Bah, Alhaji Sununu Muhsinah, Abdulwasiu J Pharm Policy Pract Commentary With an estimated population of 8.3 million, Sierra Leone has no existing pharmaceutical manufacturing company at present. The recent COVID-19 pandemic brought to the limelight the fragility and weakness of the Sierra Leonean pharmaceutical industry as it resulted in severe drug shortages and medicine insecurity in the country due to the restrictions imposed on importations, which validates the uncertainties if the country can sufficiently meet its local pharmaceutical needs and health demands. In this paper, we highlight the current situation of the Sierra Leonean pharmaceutical sector and provide recommendations for the country towards building a functional pharmaceutical industry based on lessons learnt from the COVID-19 pandemic. BioMed Central 2022-07-27 /pmc/articles/PMC9326415/ /pubmed/35897056 http://dx.doi.org/10.1186/s40545-022-00444-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Conteh, Eugene
Okereke, Melody
Turay, Foday Umaro
Bah, Alhaji Sununu
Muhsinah, Abdulwasiu
The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic
title The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic
title_full The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic
title_fullStr The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic
title_full_unstemmed The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic
title_short The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic
title_sort need for a functional pharmaceutical industry in sierra leone: lessons from the covid-19 pandemic
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326415/
https://www.ncbi.nlm.nih.gov/pubmed/35897056
http://dx.doi.org/10.1186/s40545-022-00444-w
work_keys_str_mv AT conteheugene theneedforafunctionalpharmaceuticalindustryinsierraleonelessonsfromthecovid19pandemic
AT okerekemelody theneedforafunctionalpharmaceuticalindustryinsierraleonelessonsfromthecovid19pandemic
AT turayfodayumaro theneedforafunctionalpharmaceuticalindustryinsierraleonelessonsfromthecovid19pandemic
AT bahalhajisununu theneedforafunctionalpharmaceuticalindustryinsierraleonelessonsfromthecovid19pandemic
AT muhsinahabdulwasiu theneedforafunctionalpharmaceuticalindustryinsierraleonelessonsfromthecovid19pandemic
AT conteheugene needforafunctionalpharmaceuticalindustryinsierraleonelessonsfromthecovid19pandemic
AT okerekemelody needforafunctionalpharmaceuticalindustryinsierraleonelessonsfromthecovid19pandemic
AT turayfodayumaro needforafunctionalpharmaceuticalindustryinsierraleonelessonsfromthecovid19pandemic
AT bahalhajisununu needforafunctionalpharmaceuticalindustryinsierraleonelessonsfromthecovid19pandemic
AT muhsinahabdulwasiu needforafunctionalpharmaceuticalindustryinsierraleonelessonsfromthecovid19pandemic

Ejemplares similares